OrbiMed Capital GP VIII, Director: ArriVent BioPharma AVBP Buy · Filed 24/01/31

Trade details

Type: Insider buy
Amount: $3,999,996
Shares · price: 222,222 sh · $18.00 a share
Held after: 1,513,664 sh
Stock: ArriVent BioPharma AVBP
Person: OrbiMed Capital GP VIIIDirector
Trade date: 24/01/30
Filed: 24/01/31
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 8 insiders
Holding change: +17.2%

ArriVent BioPharma trades, last 26 weeks

What else happened in ArriVent BioPharma around then

Filed or reported within 30 days of the trade day · 23/12/31~24/02/29

OrbiMed Capital GP VIII's recent trades

OrbiMed Capital GP VIIIDirector
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$4,493
101 sh
$4,493
Filed 05/29
Traded 05/27
OrbiMed Capital GP VIIIDirector
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$8.5M
184,639 sh
$8.5M
Filed 05/11
Traded 05/11
OrbiMed Capital GP VIIIDirector
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$2.7M
59,767 sh
$2.7M
Filed 05/11
Traded 05/08
OrbiMed Capital GP VIIIDirector
Sell10b5-1 planSionna Therapeutics
Sell10b5-1 plan
Sionna Therapeutics
SION
$2.2M
48,546 sh
$2.2M
Filed 05/11
Traded 05/07
OrbiMed Capital GP VIII10% Owner
BuyTraws Pharma
Buy
Traws Pharma
TRAW
$998.2K
597,729 sh
$998.2K
Filed 04/28
Traded 04/16